Effects of the AT1 receptor antagonist L-158,809 on microglia and neurogenesis after fractionated whole-brain irradiation

Radiation Research

Volumn 173, Issue 1, 2010, Pages 49-61

  Conner, Kelly R ^a   Payne, Valerie S ^a   Forbes, M Elizabeth ^a   Robbins, Mike E ^a   Riddle, David R ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 ETHYL 5,7 DIMETHYL 3 [4 [2 (2H TETRAZOL 5 YL)PHENYL]BENZYL]IMIDAZO[4,5 B]PYRIDINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BRAIN CORTEX; BRAIN RADIATION; CELL PROLIFERATION; COGNITIVE DEFECT; DRUG EFFECT; DRUG MECHANISM; HIPPOCAMPUS; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MICROGLIA; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RAT; STEM CELL;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BEHAVIOR, ANIMAL; BRAIN; CELL PROLIFERATION; COGNITION DISORDERS; DENTATE GYRUS; HUMANS; IMIDAZOLES; INFLAMMATION; MALE; MICROGLIA; NEUROGENESIS; NEURONS; RADIATION DOSAGE; RADIATION INJURIES, EXPERIMENTAL; RATS; RECEPTOR, ANGIOTENSIN, TYPE 1; RENIN-ANGIOTENSIN SYSTEM; TETRAZOLES; TIME FACTORS;

RATTUS;

EID: 73349128110     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR1821.1     Document Type: Article

References (75)

1. R. A. Patchell, The management of brain metastases. Cancer Treat. Rev. 29, 533-540 (2003).
2. A. F. Eichler and J. S. Loeffler, Multidisciplinary management of brain metastases. Oncologist 12, 884-898 (2007).
3. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, T. Murray and M. J. Thun, Cancer statistics, 2008. CA Cancer J. Clin. 58, 71-96 (2008).
4. D. Khuntia, P. Brown, J. Li and M. P. Mehta, Whole-brain radiotherapy in the management of brain metastasis. J. Clin. Oncol. 24, 1295-1304 (2006).
5. J. P. Imperato, N. A. Paleologos and N. A. Vick, Effects of treatment on long-term survivors with malignant astrocytomas. Ann. Neurol. 28, 818-822 (1990).
6. J. R. Crossen, D. Garwood, E. Glatstein and E. A. Neuwelt, Neurobehavioral sequelae of cranial irradiation in adults: a review of radiation-induced encephalopathy. J. Clin. Oncol. 12, 627-642 (1994).
7. T. B. Johannesen, H. H. Lien, K. H. Hole and K. Lote, Radiological and clinical assessment of long-term brain tumour survivors after radiotherapy. Radiother. Oncol. 69, 169-176 (2003).
8. P. J. Tofilon and J. R. Fike, The radioresponse of the central nervous system: a dynamic process. Radiat. Res. 153, 357-370 (2000).
9. M. L. Monje and T. Palmer, Radiation injury and neurogenesis. Curr. Opin. Neurol. 16, 129-134 (2003).
10. J. Raber, R. Rola, A. LeFevour, D. Morhardt, J. Curley, S. Mizumatsu, S. R. VandenBerg and J. R. Fike, Radiation-induced cognitive impairments are associated with changes in indicators of hippocampal neurogenesis. Radiat. Res. 162, 39-47 (2004). (Pubitemid 39044717)
11. R. Rola, J. Raber, A. Rizk, S. Otsuka, S. R. VandenBerg, D. R. Morhardt and J. R. Fike, Radiation-induced impairment of hippocampal neurogenesis is associated with cognitive deficits in young mice. Exp. Neurol. 188, 316-330 (2004). (Pubitemid 38891593)
12. P. R. Gard, The role of angiotensin II in cognition and behaviour. Eur. J. Pharmacol. 438, 1-14 (2002).
13. J. W. Wright, J. R. Reichert, C. J. Davis and J. W. Harding, Neural plasticity and the brain renin-angiotensin system. Neurosci. Biobehav. Rev. 26, 529-552 (2002).
14. R. M. Carey and H. M. Siragy, Newly recognized components of the renin-angiotensin system: potential roles in cardiovascular and renal regulation. Endocr. Rev. 24, 261-271 (2003).
15. L. Gendron, M. D. Payet and N. Gallo-Payet, The angiotensin type 2 receptor of angiotensin II and neuronal differentiation: from observations to mechanisms. J. Mol. Endocrinol. 31, 359-372 (2003).
16. J. Culman, J. Baulmann, A. Blume and T. Unger, The renin-angiotensin system in the brain: an update. J. Renin Angiotensin Aldosterone Syst. 2, 96-102 (2001).
17. J. Culman, A. Blume, P. Gohlke and T. Unger, The renin-angiotensin system in the brain: possible therapeutic implications for AT(1)-receptor blockers. J. Hum. Hypertens. 16 (Suppl. 3), S64-S70 (2002).
18. E. M. de Cavanagh, B. Piotrkowski and C. G. Fraga, Concerted action of the renin-angiotensin system, mitochondria, and antioxidant defenses in aging. Mol. Aspects Med. 25, 27-36 (2004).
19. J. E. Moulder, B. L. Fish and E. P. Cohen, ACE inhibitors and AII receptor antagonists in the treatment and prevention of bone marrow transplant nephropathy. Curr. Pharm. Des. 9, 737-749 (2003).
20. J. H. Kim, S. L. Brown, A. Kolozsvary, K. A. Jenrow, S. Ryu, M. L. Rosenblum and O. A. Carretero, Modification of radiation injury by ramipril, inhibitor of angiotensin-converting enzyme, on optic neuropathy in the rat. Radiat. Res. 161, 137-142 (2004).
21. A. Molteni, L. F. Wolfe, W. F. Ward, C. H. Ts'ao, L. B. Molteni, P. Veno, B. L. Fish, J. M. Taylor, N. Quintanilla and J. E. Moulder, Effect of an angiotensin II receptor blocker and two angiotensin converting enzyme inhibitors on transforming growth factor-beta (TGF-beta) and alpha-actomyosin (alpha SMA), important mediators of radiation-induced pneumopathy and lung fibrosis. Curr. Pharm. Des. 13, 1307-1316 (2007).
22. J. E. Moulder and E. P. Cohen, Future strategies for mitigation and treatment of chronic radiation-induced normal tissue injury. Semin. Radiat. Oncol. 17, 141-148 (2007).
23. R. Igic and R. Behnia, Properties and distribution of angiotensin I converting enzyme. Curr. Pharm. Des. 9, 697-706 (2003).
24. L. Shi, M. M. Adams, A. Long, C. C. Carter, C. Bennett, W. E. Sonntag, M. M. Nicolle, M. Robbins, R. D'Agostino and J. K. Brunso-Bechtold, Spatial learning and memory deficits after whole-brain irradiation are associated with changes in NMDA receptor subunits in the hippocampus. Radiat. Res. 166, 892-899 (2006).
25. W. R. Brown, R. M. Blair, D. M. Moody, C. R. Thore, S. Ahmed, M. E. Robbins and K. T. Wheeler, Capillary loss precedes the cognitive impairment induced by fractionated whole-brain irradiation: a potential rat model of vascular dementia. J. Neurol. Sci. 257, 67-71 (2007).
26. M. E. Robbins, V. Payne, E. Tommasi, D. I. Diz, F. C. Hsu, W. R. Brown, K. T. Wheeler, J. Olson and W. Zhao, The AT1 receptor antagonist, L-158, 809, prevents or ameliorates fractionated whole-brain irradiation-induced cognitive impairment. Int. J. Radiat. Oncol. Biol. Phys. 73, 499-505 (2009).
27. T. M. Madsen, P. E. Kristjansen, T. G. Bolwig and G. Wörtwein, Arrested neuronal proliferation and impaired hippocampal function following fractionated brain irradiation in the adult rat. Neuroscience 119, 635-642 (2003).
28. G. Winocur, J. M. Wojtowicz, M. Sekeres, J. S. Snyder and S. Wang, Inhibition of neurogenesis interferes with hippocampus-dependent memory function. Hippocampus 16, 296-304 (2006).
29. M. L. Monje, H. Toda and T. D. Palmer, Inflammatory blockade restores adult hippocampal neurogenesis. Science 302, 1760-1765 (2003).
30. S. Rosi, M. Andres-Mach, K. M. Fishman, W. Levy, R. A. Ferguson and J. R. Fike, Cranial irradiation alters the behaviorally induced immediate-early gene Arc (activity-regulated cytoskeleton-associated protein). Cancer Res. 68, 9763-9770 (2008).
31. D. Ehninger and G. Kempermann, Neurogenesis in the adult hippocampus. Cell Tissue Res. 331, 243-250 (2008).
32. W. R. Brown, C. R. Thore, D. M. Moody, M. E. Robbins and K. T. Wheeler, Vascular damage after fractionated whole-brain irradiation in rats. Radiat. Res. 164, 662-668 (2005).
33. T. Atwood, V. S. Payne, W. Zhao, W. R. Brown, K. T. Wheeler, J. M. Zhu and M. E. Robbins, Quantitative magnetic resonance spectroscopy reveals a potential relationship between radiation-induced changes in rat brain metabolites and cognitive impairment. Radiat. Res. 168, 574-581 (2007).
34. R. E. Clark and S. J. Martin, Interrogating rodents regarding their object and spatial memory. Curr. Opin. Neurobiol. 15, 593-598 (2005).
35. A. Ennaceur and J. Delacour, A new one-trial test for neurobiological studies of memory in rats. 1: Behavioral data. Behav. Brain Res. 31, 47-59 (1988).
36. G. Paxinos and C. Watson, The Rat Brain in Stereotaxic Coordinates. Academic Press, San Diego, 1998.
37. N. Kee, S. Sivalingam, R. Boonstra and J. M. Wojtowicz, The utility of Ki-67 and BrdU as proliferative markers of adult neurogenesis. J. Neurosci. Methods 115, 97-105 (2002).
38. D. Ito, Y. Imai, K. Ohsawa, K. Nakajima, Y. Fukuuchi and S. Kohsaka, Microglia-specific localisation of a novel calcium binding protein, Iba1. Brain Res. Mol. Brain Res. 57, 1-9 (1998).
39. J. G. Damoiseaux, E. A. Dopp, W. Calame, D. Chao, G. G. MacPherson and C. D. Dijkstra, Rat macrophage lysosomal membrane antigen recognized by monoclonal antibody ED1. Immunology 83, 140-147 (1994).
40. J. P. Brown, S. Couillard-Despres, C. M. Cooper-Kuhn, J. Winkler, L. Aigner and H. G. Kuhn, Transient expression of doublecortin during adult neurogenesis. J. Comp. Neurol. 467, 1-10 (2003).
41. H. J. Gundersen, T. F. Bendtsen, L. Korbo, N. Marcussen, A. Moller, K. Nielsen, J. R. Nyengaard, B. Pakkenberg, F. B. Sorensen and M. J. West, Some new, simple and efficient stereological methods and their use in pathological research and diagnosis. Acta Pathol. Microbiol. Immunol. Scand. 96, 379-394 (1988).
42. R. J. Lichtenwalner, M. E. Forbes, S. A. Bennett, C. D. Lynch, W. E. Sonntag and D. R. Riddle, Intracerebroventricular infusion of insulin-like growth factor-I ameliorates the age-related decline in hippocampal neurogenesis. Neuroscience 107, 603-613 (2001).
43. M. K. Schindler, M. E. Forbes, M. E. Robbins and D. R. Riddle, Aging-dependent changes in the radiation response of the adult rat brain. Int. J. Radiat. Oncol. Biol. Phys. 70, 826-834 (2008).
44. M. J. West, L. Slomianka and H. J. Gundersen, Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator. Anat. Rec. 231, 482-497 (1991).
45. I. G. Newton, M. E. Forbes, M. C. Linville, H. Pang, E. W. Tucker, D. R. Riddle and J. K. Brunso-Bechtold, Effects of aging and caloric restriction on dentate gyrus synapses and glutamate receptor subunits. Neurobiol. Aging 29, 1308-1318 (2008).
46. M. B. Moser, E. I. Moser, E. Forrest, P. Andersen and R. G. Morris, Spatial learning with a minislab in the dorsal hippocampus. Proc. Natl. Acad. Sci. USA 92, 9697-9701 (1995).
47. M. B. Moser and E. I. Moser, Functional differentiation in the hippocampus. Hippocampus 8, 608-619 (1998).
48. C. Schmitz and P. R. Hof, Recommendations for straightforward and rigorous methods of counting neurons based on a computer simulation approach. J. Chem. Neuroanat. 20, 93-114 (2000).
49. R. Ladeby, M. Wirenfeldt, D. Garcia-Ovejero, C. Fenger, L. Dissing-Olesen, I. Dalmau and B. Finsen, Microglial cell population dynamics in the injured adult central nervous system. Brain Res. Brain Res. Rev. 48, 196-206 (2005).
50. W. J. Streit, Microglia and neuroprotection: implications for Alzheimer's disease. Brain Res. Brain Res. Rev. 48, 234-239 (2005).
51. T. Town, V. Nikolic and J. Tan, The microglial "activation" continuum: from innate to adaptive responses. J. Neuroin-flammation 2, 24 (2005).
52. S. Mizumatsu, M. L. Monje, D. R. Morhardt, R. Rola, T. D. Palmer and J. R. Fike, Extreme sensitivity of adult neurogenesis to low doses of X-irradiation. Cancer Res. 63, 4021-4027 (2003).
53. Y. Han, M. S. Runge and A. R. Brasier, Angiotensin II induces interleukin-6 transcription in vascular smooth muscle cells through pleiotropic activation of nuclear factor-kappa B transcription factors. Circ. Res. 84, 695-703 (1999).
54. I. Moeller, A. M. Allen, S. Y. Chai, J. Zhuo and F. A. Mendelsohn, Bioactive angiotensin peptides. J. Hum. Hypertens. 12, 289-293 (1998).
55. E. L. Schiffrin, Vascular and cardiac benefits of angiotensin receptor blockers. Am. J. Med. 113, 409-418 (2002).
56. A. Fournier, J. M. Achard, F. Boutitie, H. Mazouz, J. Mansour, R. Oprisiu, L. Fernandez and F. Messerli, Is the angiotensin II type 2 receptor cerebroprotective? Curr. Hypertens. Rep. 6, 182-189 (2004).
57. C. Thone-Reineke, M. Zimmermann, C. Neumann, M. Krikov, J. Li, N. Gerova and T. Unger, Are angiotensin receptor blockers neuroprotective? Curr. Hypertens. Rep. 6, 257-266 (2004).
58. M. L. Monje, S. Mizumatsu, J. R. Fike and T. D. Palmer, Irradiation induces neural precursor-cell dysfunction. Nat. Med. 8, 955-962 (2002).
59. Y. Suzuki, M. Ruiz-Ortega, O. Lorenzo, M. Ruperez, V. Esteban and J. Egido, Inflammation and angiotensin II. Int. J. Biochem. Cell Biol. 35, 881-900 (2003).
60. M. Ruiz-Ortega, V. Esteban and J. Egido, The regulation of the inflammatory response through nuclear factor-kappab pathway by angiotensin IV extends the role of the renin angiotensin system in cardiovascular diseases. Trends Cardiovasc. Med. 17, 19-25 (2007).
61. P. Gohlke, S. Weiss, A. Jansen, W. Wienen, J. Stangier, W. Rascher, J. Culman and T. Unger, AT1 receptor antagonist telmisartan administered peripherally inhibits central responses to angiotensin II in conscious rats. J. Pharmacol. Exp. Ther. 298, 62-70 (2001).
62. J. E. Moulder, B. L. Fish and E. P. Cohen, Angiotensin II receptor antagonists in the treatment and prevention of radiation nephropathy. Int. J. Radiat. Biol. 73, 415-421 (1998).
63. S. Gilliam-Davis, V. S. Payne, S. O. Kasper, E. N. Tommasi, M. E. Robbins and D. I. Diz, Long-term AT1 receptor blockade improves metabolic function and provides renoprotection in Fischer-344 rats. Am. J. Physiol. Heart Circ. Physiol. 293, H1327-H1333 (2007).
64. C. Zoja, M. Abbate, D. Corna, M. Capitanio, R. Donadelli, I. Bruzzi, S. Oldroyd, A. Benigni and G. Remuzzi, Pharmacologic control of angiotensin II ameliorates renal disease while reducing renal TGF-beta in experimental mesangioproliferative glomerulonephritis. Am. J. Kidney Dis. 31, 453-463 (1998).
65. P. K. Datta, J. E. Moulder, B. L. Fish, E. P. Cohen and E. A. Lianos, TGF-beta 1 production in radiation nephropathy: role of angiotensin II. Int. J. Radiat. Biol. 75, 473-479 (1999).
66. A. Molteni, J. E. Moulder, E. F. Cohen, W. F. Ward, B. L. Fish, J. M. Taylor, L. F. Wolfe, L. Brizio-Molteni and P. Veno, Control of radiation-induced pneumopathy and lung fibrosis by angiotensin-converting enzyme inhibitors and an angiotensin II type 1 receptor blocker. Int. J. Radiat. Biol. 76, 523-532 (2000).
67. W. J. Streit, J. R. Conde, S. E. Fendrick, B. E. Flanary and C. L. Mariani, Role of microglia in the central nervous system's immune response. Neurol. Res. 27, 685-691 (2005).
68. K. Nakajima and S. Kohsaka, Microglia: neuroprotective and neurotrophic cells in the central nervous system. Curr. Drug Targets Cardiovasc. Haematol. Disord. 4, 65-84 (2004).
69. R. Rola, V. Sarkissian, A. Obenaus, G. A. Nelson, S. Otsuka, C. L. Limoli and J. R. Fike, High-LET radiation induces inflammation and persistent changes in markers of hippocampal neurogenesis. Radiat. Res. 164, 556-560 (2005).
70. L. Shi, D. P. Molina, M. E. Robbins, K. T. Wheeler and J. K. Brunso-Bechtold, Hippocampal neuron number is unchanged 1 year after fractionated whole-brain irradiation at middle age. Int. J. Radiat. Oncol. Biol. Phys. 71, 526-532 (2008).
71. J. W. Wright and J. W. Harding, Brain angiotensin receptor subtypes in the control of physiological and behavioral responses. Neurosci. Biobehav. Rev. 18, 21-53 (1994).
72. D. L. Armstrong, E. A. Garcia, T. Ma, B. Quinones and M. J. Wayner, Angiotensin II blockade of long-term potentiation at the perforant path-granule cell synapse in vitro. Peptides 17, 689-693 (1996).
73. A. Blume, T. Herdegen and T. Unger, Angiotensin peptides and inducible transcription factors. J. Mol. Med. 77, 339-357 (1999).
74. H. L. Pan, Brain angiotensin II and synaptic transmission. Neuroscientist 10, 422-431 (2004).
75. O. K. Abayomi, Pathogenesis of irradiation-induced cognitive dysfunction. Acta Oncol. 35, 659-663 (1996).